Direkt zum Inhalt
Merck
  • Inhibitory effect of nonviable preparations from human immunodeficiency virus 1 on inositol phospholipid metabolism.

Inhibitory effect of nonviable preparations from human immunodeficiency virus 1 on inositol phospholipid metabolism.

European journal of biochemistry (1989-08-01)
W E Müller, P Reuter, Y Kuchino, J van Rooyen, H C Schröder
ZUSAMMENFASSUNG

Previously it was established [Pahwa, S., Pahwa, R., Saxinger, C., Gallo, R. C. & Good, R. A. (1985) Proc. Natl. Acad. Sci. USA 82, 8198] that nonviable preparations of human immunodeficiency virus 1 (HIV-1) abolish the proliferative response of human lymphocytes to phytohemagglutinin A. Now we describe that this effect might be, at least partially, due to an impairment of the function of phospholipase C. It was found that addition of HIV-1 preparation to lymphocytes diminished the stimulation of phosphatidylinositol phosphorylation caused by phytohemagglutinin A. Moreover, this preparation completely abolished the phytohemagglutinin-A-stimulated release of inositol trisphosphate and prevented a translocation of protein kinase C from cytosol to membranes. From this data we conclude that nonviable HIV-1 preparations inhibit the intracellular signalling pathway, leading to a reduced mitogenic response to phytohemagglutinin A, at the level of protein kinase C.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Lektin von der Phytolacca americana (Kermesbeere), lyophilized powder